This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Jorge Correale: Innovator in Autoimmune Disease Treatment
Introduction
Jorge Correale is a prominent inventor based in Buenos Aires, Argentina. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. His innovative approach focuses on the use of melatonin to address seasonal worsening of multiple sclerosis.
Latest Patents
Jorge Correale holds a patent titled "Melatonin in autoimmune disease - Methods for treating, or reducing risk of developing, seasonal worsening of multiple sclerosis (MS) in a subject who has MS, comprising administering a melatonin agonist to a subject." This patent highlights his commitment to advancing therapeutic options for individuals suffering from multiple sclerosis.
Career Highlights
Correale is affiliated with The Brigham and Women's Hospital, Inc., where he continues to conduct research and develop new treatment methodologies. His work has garnered attention for its potential to improve the quality of life for patients with autoimmune conditions.
Collaborations
Jorge Correale has collaborated with notable colleagues in his field, including Francisco Javier Quintana and Mauricio Farez. These partnerships have facilitated the exchange of ideas and fostered advancements in research related to autoimmune diseases.
Conclusion
Jorge Correale's innovative work in the treatment of multiple sclerosis through melatonin administration exemplifies the impact of dedicated research in the medical field. His contributions continue to inspire advancements in the management of autoimmune diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
